[#DIV28SUPER] Fw: Final Recommendation Statement: Screening for Unhealthy Drug Use

Forwarding on behalf of Jacob Marzalik.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science

Clinical Research Support Office

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

---

From: Marzalik, Jacob <JMarzalik@apa.org>
Sent: Wednesday, June 10, 2020 10:41 AM
To: DIV28SUPER-request@LISTS.APA.ORG <DIV28SUPER-request@LISTS.APA.ORG>
Subject: FW: Final Recommendation Statement: Screening for Unhealthy Drug Use

 

CAUTION: External Sender

Hi,

 

Would you mind forwarding the previous two emails below to Division 28 colleagues for their reference?

 

Many thanks,

Jacob

 

Jacob S. Marzalik, MA

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

From: Marzalik, Jacob
Sent: Wednesday, June 10, 2020 10:39 AM
To: div28super@lists.apa.org
Cc: Halfond, Raquel <rhalfond@apa.org>
Subject: FW: Final Recommendation Statement: Screening for Unhealthy Drug Use

 

Hello Division 28 colleagues,

 

The U.S. Preventive Services Task Force just released final recommendations and an evidence summary on Screening for Unhealthy Drug Use. A clinician summary is also available on the Task Force website, which provides guidance to primary care clinicians for using the recommendation in practice. See below for more information

 

Please forward to interested colleagues.

 

Thank you.

 

Jacob S. Marzalik, MA

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

 

750 First Street NE, Washington, DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

From: Agency for Healthcare Research and Quality (AHRQ) <updates@subscriptions.ahrq.gov>
Sent: Tuesday, June 9, 2020 11:04 AM
To: Marzalik, Jacob <JMarzalik@apa.org>
Subject: Final Recommendation Statement: Screening for Unhealthy Drug Use

 

 

June 9, 2020 Final Recommendation Statement: Screening for Unhealthy Drug Use Final Recommendation Statement: Screening for Unhealthy Drug Use The U.S. Preventive Services Task Force released today a final recommendation statement on screening for unhealthy drug use. That Task Force found that clinicians should ask adults about their drug use and connect people who have a problem to care. More research is needed to make a recommendation for teens. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. The final recommendation statement can also be found in the June 9, 2020 online issue of JAMA. The Final Recommendation Statement Is Available FINAL RECOMMENDATION SUMMARY See the full statement Population Recommendation Grade Adults age 18 years or older The USPSTF recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.) B Adolescents The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for unhealthy drug use in adolescents. See the "Practice Considerations" section for suggestions for practice regarding the I statement. I WHY THIS MATTERS "The physical, mental, and social effects of drug use can be grave for both individuals and families," says Task Force vice chair Karina Davidson, Ph.D., M.A.Sc. "The good news is that primary care clinicians can help by asking adults about their drug use and providing a connection to treatment and support for those who need it." WHERE WE ARE IN THE PROCESS Draft Research Plan Final Research Plan Draft Recommendation / Draft Evidence Review  Final Recommendation / Evidence Summary

---

This email was sent to jmarzalik@apa.org using GovDelivery Communications Cloud on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 5600 Fishers Lane, Rockville, MD 20857 · 301-427-1364

---

CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe.